Loading...
XASXMVF
Market cap297mUSD
Jan 10, Last price  
1.24AUD
1D
-1.59%
1Q
2.48%
Jan 2017
-39.51%
IPO
-31.11%
Name

Monash IVF Group Ltd

Chart & Performance

D1W1MN
XASX:MVF chart
P/E
—
P/S
1.89
EPS
—
Div Yield, %
3.79%
Shrs. gr., 5y
3.60%
Rev. gr., 5y
10.90%
Revenues
255m
+19.37%
96,598,000114,012,000124,955,000156,561,000155,182,000150,638,000151,980,000145,417,000183,605,000192,294,000213,590,000254,960,000
Net income
-7m
L
-14,856,0002,581,00021,373,00028,775,00029,619,00021,353,00019,852,00011,726,00025,148,00018,406,00021,839,000-6,527,000
CFO
53m
+38.38%
30,106,00036,222,00036,008,00044,162,00025,909,00025,930,00033,093,00026,542,00043,254,00031,276,00037,952,00052,519,000
Dividend
Sep 05, 20240.025 AUD/sh
Earnings
Feb 20, 2025

Profile

Monash IVF Group Limited provides assisted reproductive and specialist women imaging services in Australia and Malaysia. The company offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. It also provides tertiary level prenatal diagnostic and IVF treatment services. The company was incorporated in 2014 and is based in Richmond, Australia.
URL
https://www.monashivfgroup.com.au/
IPO date
Jun 26, 2014
Employees
867
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑062015‑06
Income
Revenues
254,960
19.37%
213,590
11.07%
192,294
4.73%
Cost of revenue
265,999
168,389
153,480
Unusual Expense (Income)
NOPBT
(11,039)
45,201
38,814
NOPBT Margin
21.16%
20.18%
Operating Taxes
(4,707)
7,873
7,720
Tax Rate
17.42%
19.89%
NOPAT
(6,332)
37,328
31,094
Net income
(6,527)
-129.89%
21,839
18.65%
18,406
-26.81%
Dividends
(18,323)
(17,144)
(16,753)
Dividend yield
3.65%
3.80%
4.55%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
7,990
(4,143)
7,131
Long-term debt
203,185
148,548
70,099
Deferred revenue
60,335
Other long-term liabilities
15,610
6,610
1,920
Net debt
198,249
134,652
68,135
Cash flow
Cash from operating activities
52,519
37,952
31,276
CAPEX
(20,819)
(27,789)
(11,763)
Cash from investing activities
(38,800)
(40,508)
(15,162)
Cash from financing activities
(10,391)
2,678
(17,016)
FCF
9,516
26,605
(2,386)
Balance
Cash
11,333
8,005
7,874
Long term investments
1,593
1,748
1,221
Excess cash
178
Stockholders' equity
246,659
275,074
269,893
Invested Capital
397,461
381,723
348,586
ROIC
10.22%
9.41%
ROCE
11.84%
10.92%
EV
Common stock shares outstanding
389,635
392,425
391,543
Price
1.29
12.17%
1.15
22.34%
0.94
10.59%
Market cap
502,629
11.38%
451,289
22.62%
368,050
10.76%
EV
705,632
587,814
438,161
EBITDA
7,539
60,544
53,602
EV/EBITDA
93.60
9.71
8.17
Interest
5,368
3,304
2,151
Interest/NOPBT
7.31%
5.54%